Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price dropped 1.7% during trading on Friday . The company traded as low as $0.9801 and last traded at $0.9931. Approximately 351,516 shares were traded during mid-day trading, an increase of 424% from the average daily volume of 67,097 shares. The stock had previously closed at $1.01.
Cardiol Therapeutics Trading Up 4.2%
The company has a fifty day simple moving average of $1.04 and a 200-day simple moving average of $1.16.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
Featured Stories
- Five stocks we like better than Cardiol Therapeutics
- A month before the crash
- Do not delete, read immediately
- 1 Hour Once A Day
- A Message From An Ex-CIA Officer About Trump
- ALERT: Drop these 5 stocks before January 2026!
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
